REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Thoyyib Pharma Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Thoyyib Pharma Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

To manufacture, produce, buy, sell whether retail or wholesale and otherwise deal in all kinds of medicine, pharmaceuticals. to deal, manage, manufacture and marketing of cosmetic products. to manufacture, produce, buy and sell of food supplements.

Headquarters
No. 83/84, Jalan Nilai 3/23, Nilai 3 Industrial Park
Nilai; Negeri Sembilan; Postal Code: 71800

Contact Details: Purchase the Thoyyib Pharma Sdn. Bhd. report to view the information.

Website: http://www.thoyyibpharma.com

Basic Information
Total Employees:
Purchase the Thoyyib Pharma Sdn. Bhd. report to view the information.
Outstanding Shares:
Purchase the Thoyyib Pharma Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Thoyyib Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Thoyyib Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
May 31, 2001
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Thoyyib Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-4.04%▼
Total operating revenue
-4.04%▼
Operating profit (EBIT)
-47.23%▼
Net Profit (Loss) for the Period
-49.6%▼
Total assets
4.29%▲
Total equity
55.21%▲
Operating Profit Margin (ROS)
-8.59%▼
Net Profit Margin
-7.35%▼
Return on Equity (ROE)
-83.33%▼
Quick Ratio
0.13%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo